{"id":53217,"date":"2023-01-24T11:02:45","date_gmt":"2023-01-24T10:02:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/"},"modified":"2023-01-24T11:02:45","modified_gmt":"2023-01-24T10:02:45","slug":"gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/","title":{"rendered":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors"},"content":{"rendered":"<div>\n<p>VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the appointment of Brenda G. Cooperstone, MD, as an independent member of its Board of Directors. Dr. Cooperstone is a pharmaceutical executive with more than 20 years of experience in drug development. She most recently served as the Chief Development Officer, Rare Diseases and the Pennsylvania Site Head for Pfizer Inc.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/5\/BrendaGCooperstone.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693083\/5\/Gandeeva_ID_F.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693083\/21\/Gandeeva_ID_F.jpg\"><\/a><\/p>\n<p>\n\u201cWe are excited to welcome Dr. Cooperstone to Gandeeva\u2019s Board of Directors,\u201d said Sriram Subramaniam, Ph.D., Founder and CEO of Gandeeva Therapeutics. \u201cDr. Cooperstone brings significant clinical development, regulatory, and portfolio strategy experience to our team, and we are thrilled to work with her as we advance our pipeline of innovative medicines to the clinic.\u201d\n<\/p>\n<p>\n\u201cI am delighted to join Gandeeva\u2019s Board as the company works to achieve its groundbreaking vision of combining detailed structural understanding of proteins with cryo-EM and machine learning to develop a pipeline of differentiated drugs in oncology and other therapeutic areas,\u201d remarked Dr. Cooperstone.\n<\/p>\n<p>\nPrior to joining Gandeeva Therapeutics\u2019 Board of Directors, Brenda Cooperstone held key leadership positions as Pfizer\u2019s Chief Development Officer, Rare Diseases, as well as Site Head in Collegeville, PA. Dr. Cooperstone also held various leadership positions at Pfizer and Wyeth across different therapeutic areas from early to late-stage clinical development and global medical affairs. Dr. Cooperstone was a pediatric nephrologist at the Scottish Rite Children\u2019s Medical Center, an immunology research fellow at the University of Pennsylvania\u2019s Renal Electrolyte Section, and a clinical fellow in pediatric nephrology at Children\u2019s Hospital of Philadelphia. Dr. Cooperstone earned her M.D. at McGill University and completed her clinical residency at the Montreal Children\u2019s Hospital in pediatrics. Dr. Cooperstone also serves as an independent board member at Senti Biosciences.\n<\/p>\n<p>\nAbout Gandeeva Therapeutics\n<\/p>\n<p>\nGandeeva Therapeutics is a precision biotechnology company integrating the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop differentiated therapeutics by targeting and modulating key protein-protein interactions. Gandeeva\u2019s structure-guided drug discovery platform encompasses target prediction and validation (SPOTLIGHT\u2122), hit identification by screening virtual and fragment libraries (HYPERFOCUS\u2122), and lead optimization (CRYO-CADD\u2122). Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (iGlues\u2122) and allosteric inhibitors. Gandeeva is headquartered in the Greater Vancouver area, Canada. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gandeeva.com&amp;esheet=53289743&amp;newsitemid=20230123005821&amp;lan=en-US&amp;anchor=www.gandeeva.com&amp;index=1&amp;md5=d49b03a607a58aca96c139050d4c6651\" rel=\"nofollow noopener\" shape=\"rect\">www.gandeeva.com<\/a> or follow us on LinkedIn and Twitter.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nEmily Wight<br \/>\n<br \/>Communications Manager, Gandeeva Therapeutics<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;l&#x74;&#111;&#x3a;&#69;m&#x69;l&#x79;&#46;&#x77;&#105;&#x67;&#104;t&#x40;g&#x61;&#110;&#x64;&#101;&#x65;&#x76;a&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x45;&#109;&#x69;&#x6c;&#121;&#x2e;&#x77;&#105;&#x67;&#x68;&#116;&#x40;&#x67;a&#x6e;&#x64;e&#x65;&#118;a&#x2e;&#99;o&#x6d;<\/a><br \/>+1 778-726-4194\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the appointment of Brenda G. Cooperstone, MD, as an independent member of its Board of Directors. Dr. Cooperstone is a pharmaceutical executive with more than 20 years of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53217","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the appointment of Brenda G. Cooperstone, MD, as an independent member of its Board of Directors. Dr. Cooperstone is a pharmaceutical executive with more than 20 years of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-24T10:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors\",\"datePublished\":\"2023-01-24T10:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/\"},\"wordCount\":441,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005821\\\/en\\\/1693839\\\/21\\\/BrendaGCooperstone.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/\",\"name\":\"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005821\\\/en\\\/1693839\\\/21\\\/BrendaGCooperstone.jpg\",\"datePublished\":\"2023-01-24T10:02:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005821\\\/en\\\/1693839\\\/21\\\/BrendaGCooperstone.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005821\\\/en\\\/1693839\\\/21\\\/BrendaGCooperstone.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend","og_description":"VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the appointment of Brenda G. Cooperstone, MD, as an independent member of its Board of Directors. Dr. Cooperstone is a pharmaceutical executive with more than 20 years of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-24T10:02:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors","datePublished":"2023-01-24T10:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/"},"wordCount":441,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/","name":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg","datePublished":"2023-01-24T10:02:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230123005821\/en\/1693839\/21\/BrendaGCooperstone.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gandeeva-therapeutics-announces-appointment-of-dr-brenda-g-cooperstone-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53217"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53217\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}